Jupiter Neurosciences, Inc.JUNSNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P56
Within normal range
vs 2Y Ago
0.4x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q3 2025 | 7.54% |
| Q2 2025 | 62.71% |
| Q1 2025 | 132.21% |
| Q4 2024 | 118.70% |
| Q3 2024 | -9.07% |
| Q2 2024 | 2.44% |
| Q1 2024 | -59.68% |
| Q4 2023 | 2.20% |
| Q3 2023 | 17.85% |
| Q2 2023 | -24.01% |
| Q1 2023 | 0.00% |
| Q2 2022 | 38.03% |
| Q1 2022 | -50.92% |
| Q4 2021 | 24.89% |
| Q3 2021 | -39.74% |
| Q2 2021 | 74.77% |
| Q1 2021 | -67.84% |
| Q4 2020 | 137.33% |
| Q3 2020 | 0.00% |